Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019
Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of Anluohuaxian in blocking the progression of pulmonary
fibrosis and improving lung function in patients with COVID-19.